KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Capital Employed (2016 - 2025)

Vertex Pharmaceuticals has reported Return on Capital Employed over the past 16 years, most recently at 0.2% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.2% for Q4 2025, up 21.0% from a year ago — trailing twelve months through Dec 2025 was 0.2% (up 21.0% YoY), and the annual figure for FY2025 was 0.21%, up 22.0%.
  • Return on Capital Employed for Q4 2025 was 0.2% at Vertex Pharmaceuticals, down from 0.2% in the prior quarter.
  • Over the last five years, Return on Capital Employed for VRTX hit a ceiling of 0.33% in Q2 2022 and a floor of 0.04% in Q1 2025.
  • Median Return on Capital Employed over the past 5 years was 0.22% (2023), compared with a mean of 0.19%.
  • Biggest five-year swings in Return on Capital Employed: fell -26bps in 2024 and later increased 22bps in 2025.
  • Vertex Pharmaceuticals' Return on Capital Employed stood at 0.26% in 2021, then rose by 15bps to 0.29% in 2022, then plummeted by -30bps to 0.21% in 2023, then crashed by -106bps to 0.01% in 2024, then soared by 1677bps to 0.2% in 2025.
  • The last three reported values for Return on Capital Employed were 0.2% (Q4 2025), 0.2% (Q3 2025), and 0.2% (Q2 2025) per Business Quant data.